Biotech

All Articles

BMS axes bispecific months after submitting to work stage 3 test

.Bristol Myers Squibb has actually had a whiplash change of mind on its own BCMA bispecific T-cell e...

Charles Baum manages Terremoto as CEO

.Charles Baum, M.D., Ph.D., who supervised Mirati Therapies' $ 5.8 billion sale to Bristol Myers Squ...

Asarina to shut after attempts to companion Tourette's medication fall short

.After reaching out to greater than 200 business to companion a Tourette disorder therapy that revea...

Novartis pens $150M ahead of time bispecifics manage Dren Biography

.Novartis has actually possessed some rotten luck along with bispecific antitoxins over the last, bu...

AstraZeneca vegetations an EGFR plant along with Pinetree bargain worth $45M

.Pinetree Rehabs are going to assist AstraZeneca plant some trees in its own pipe along with a brand...

GRO rounds up $60M series B to take gout pain therapy right into center

.GRO Biosciences has actually ended the full week with an added $60.3 thousand in the banking compan...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava loses CEO

.Invite to this week's Chutes &amp Ladders, our summary of substantial leadership hirings, shootings...